Sílvia Pascual

Sílvia Pascual has extensive work experience in the pharmaceutical industry. Sílvia has held various roles at multiple companies.

Sílvia began their career at GMG Biobussiness, where they worked part-time as a Regulatory Affairs Executive, reviewing and analyzing innovative and biotechnology products authorized for marketing through the EU Centralised Procedure.

Sílvia then joined GlaxoSmithKline as a Regulatory Affairs Executive, where they were responsible for the registration strategy in Latin-American countries and was a member of the international team handling respiratory and oncologic products.

Sílvia then moved on to Grifols, S.A. as a Clinical Project Manager, where they were responsible for pharmacovigilance and the management of clinical projects.

After that, they worked at Almirall as a Clinical Trial Manager, where they planned and executed clinical trials and controlled the set-up of study centers and investigator meetings.

Sílvia continued their career at Almirall as GCO (Global Clinical Operations) Support, collaborating with the Head of GCO in financial aspects and managing the budget and forecast of clinical trials.

Currently, Sílvia holds the position of VP Clinical Development at Minoryx Therapeutics, where they oversee clinical development activities.

Sílvia Pascual completed their Bachelor's degree in Pharmacy at Universitat de Barcelona from 1993 to 1998. From 1998 to 1999, they pursued a Master's degree in Pharmacy at King's College London. In 2003, they enrolled in the Business Management Program at Universitat Oberta de Catalunya, completing it in 2004.